Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find a Doctor
Richard Martin, MD

Richard Martin, MD

  • Specialty: Neonatology
    View Expertise
  • Languages Spoken: English, German

Biography: Richard Martin, MD


  • Neonatology


  • Director, Neonatal Research Programs, UH Cleveland Medical Center
  • Professor, CWRU School of Medicine
  • Drusinsky-Fanaroff Chair in Neonatology, UH Rainbow Babies & Children's Hospital

Certifications & Memberships

  • Neonatal/Perinatal Medicine - American Board of Pediatrics
  • Pediatrics - American Board of Pediatrics


Fellowship | Neonatal-Perinatal Medicine
Neonatal-Perinatal Medicine - University Hospitals Of Cleveland (1974 - 1976)

Residency | Pediatrics
Pediatrics - University Of Missouri Healthcare - University Hospitals And Clinics (1972 - 1974)

Residency | Pediatrics
Pediatrics - Royal North Shore Hospital (1970 - 1972)

Medical Education
University Of Sydney - Sydney Medical School (1970)


Richard J. Martin, MD, is the inaugural holder of the Drusinsky/Fanaroff Chair in Neonatology at University Hospitals Rainbow Babies & Children’s Hospital, and Professor of Pediatrics, Reproductive Biology, and Physiology & Biophysics at Case Western Reserve University School of Medicine. He was raised and educated in Australia, and received his medical degree from the University of Sydney School of Medicine. His 46 year academic career has been spent entirely at UH Rainbow Babies & Children’s Hospitals, where he has served as Division Chief of Neonatology, and currently serves as the Division’s Director of Research. During his tenure at UH Rainbow, he has provided care for a multitude of sick neonates in one of the nation’s premiere NICUs.

Dr. Martin is a most sought after national and international expert in the field of developmental respiratory neurobiology. His research is focused primarily on control of breathing and lung and airway injury during early postnatal life. His research has explored basic biologic mechanisms that have led to a better understanding of clinical neonatal problems, and have resulted in improved clinical care. He has served, and continues to serve on the steering committees of several multicenter clinical trials that have impacted neonatal care. He has been funded by the NIH for over 40 years, and has trained many of the leaders in Academic Neonatology in the United States and abroad.

Dr. Martin is senior editor of the major neonatal text, Neonatal-Perinatal Medicine, now in its 11th edition, along with Avroy A. Fanaroff, MD, and Michele C. Walsh, MD. Also to his credit are over 200 first- and/or co-authored articles in peer-reviewed journals, and more than 100 chapters and reviews published in well-known books in the medical field. He serves on numerous editorial boards, is past Chair of the Sub-Board of Neonatal/ Perinatal Medicine of the American Board of Pediatrics. He received the 2017 Virginia Apgar Award of the American Academy of Pediatrics, and the 2018 Mary Ellen Avery Award of the American Pediatric Society, as well as the Legends of Neonatology Award in 2018. These awards reflect the highest level of recognition in the field of neonatology.

Research & Publications

Research Interests

Studies in airway constriction, nitric oxide, arginase, neonatal apnea

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Richard Martin did not disclose any Outside Relationships with Industry.